Twi Pharms`s Generic Terbutaline Sulfate Receives Approval in US
AstraZeneca ($AZN) said last week it was closing a plant in India that made the API for asthma drugs, noting there is not much demand any longer for the terbutaline sulfate it makes. But what the U.K. company did not say was that before its closing, the plant produced a year's worth of product that Swedish regulators say are suspect and want recalled.